Web2 mar 2024 · Hikma has once again downgraded its expectations for its generics business in 2024 as it revealed a first-half drop of 18% in sales for the unit. However, injectables and branded increases helped to offset the decline, while the company maintained that generics growth was on the horizon in 2024. Web26 dic 2024 · The company has established a diversified R&D pipeline comprising over 50 drug candidates, with five therapeutic focus areas covering cancer, autoimmune, metabolic, neurological, and infectious ...
Hikma Launches New 503B Sterile Compounding Business - PR …
Web5 apr 2024 · In connection with the settlement, Jazz has granted Hikma and its wholly owned subsidiary, West-Ward Pharmaceuticals Corp. (West-Ward), the right to sell an authorized generic (AG) version of Xyrem in the U.S. under the Xyrem New Drug Application (NDA), commencing on January 1, 2024, or earlier under certain … Web27 set 2024 · The Custopharm acquisition complements Hikma’s injectable product portfolio and pipeline. Credit: v-a-n-3-ss-a / Pixabay. Hikma Pharmaceuticals has agreed to acquire US-based Custopharm from Water Street Healthcare Partners in a deal worth $425m to strengthen its injectables business in the country. blue mountain vineyard walla walla
Hikma Pharmaceuticals to Buy Generic Drug Maker …
Web22 apr 2024 · Hikma Pharmaceuticals has acquired US-based generic sterile injectables company Custopharm from Water Street Healthcare Partners in a deal valued at $425m. The move comes after the US Federal Trade Commission granted conditional approval to conclude the acquisition. In September last year, Hikma entered an agreement to … Web30 apr 2024 · Drugs Associated with Hikma Pharmaceuticals USA Inc. Hikma Pharmaceuticals USA Inc. manufactures, markets and/or distributes more than 185 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on … Web1 giorno fa · Generic drugmaker Hikma Pharmaceuticals Plc said on Wednesday Riad Mishlawi, president of the group's injectables business, will become its chief executive officer, effective Sept. 1. blue mountain village shops